A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

Clinical trial NCT06973005 · COMPLETED

Trial details

NCT number: NCT06973005
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Chronic Liver Disease Healthy Participants

Start date: 2025-05-08
Primary completion: 2025-07-18
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.